Cui Xiangmin
SEC CIK 1487815 · EDGAR
BoughtSold
Most active insiders at BYSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Decheng Capital Global Healthcare GP, LLC | 10% | — | $283.9K |
| 2 | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | — | $227.7K |
| 3 | Decheng Capital Management III (Cayman), LLC | 10% | — | $39.0K |
| 4 | Cui Xiangmin | 10% | — | $13.8K |
| 5 | Huang Lan | CEO, Dir, 10% | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-10-02 | 2025-09-30+ | BYSI | BeyondSpring Inc. | Cui Xiangmin | 10% | S - Sale | $1.80 | -7,665 | 1.84M | -0.4% | -$13.8K |
| MI | 2025-09-03 | 2025-08-29+ | BYSI | BeyondSpring Inc. | Cui Xiangmin | 10% | S - Sale | $1.78 | -4,870 | 1.90M | -0.3% | -$8,675 |
| MI | 2025-08-15 | 2025-08-14+ | BYSI | BeyondSpring Inc. | Cui Xiangmin | 10% | S - Sale | $2.00 | -4,900 | 1.97M | -0.2% | -$9,800 |
| MI | 2025-08-11 | 2025-06-17+ | BYSI | BeyondSpring Inc. | Cui Xiangmin | 10% | S - Sale | $3.05 | -394.4K | 934.1K | -30% | -$1.20M |
| DMI | 2024-09-05 | 2024-09-04 | NUVB | Nuvation Bio Inc. | Cui Xiangmin | Dir | C - Cnv Deriv | — | +19.00M | 7.61M | New | — |
| I | 2024-06-26 | 2024-06-25 | NUVB | Nuvation Bio Inc. | Cui Xiangmin | Dir | P - Purchase | $2.97 | +277.9K | 2.45M | +13% | +$825.3K |
| MI | 2024-06-25 | 2024-06-20+ | NUVB | Nuvation Bio Inc. | Cui Xiangmin | Dir | P - Purchase | $2.98 | +500.0K | 1.76M | +40% | +$1.49M |
| MI | 2024-04-11 | 2024-04-09 | NUVB | Nuvation Bio Inc. | Cui Xiangmin | Dir | A - Grant | — | +6.17M | 4.18M | New | — |
Purchase Sale Sale after option exercise All abbreviations